A degradable mesoporous silicon nano drug delivery system modified by peoz and polydopamine-gadolinium ion network and its preparation method
An ion network, polydopamine technology, applied in nano-drugs, nano-technology, pharmaceutical formulations, etc., can solve the problems of lack of existing space and transport pathways, hidden dangers of body damage, and the inability of treatment methods to fully meet the needs of precise tumor treatment. The effect of improving delivery efficiency and comprehensive therapeutic effect, good degradability in vivo, improving the ability of degradation and MRI imaging
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0046] Example 1 Preparation of degradable mesoporous silicon nanoparticles (MSN-Man-DOX@PDA-Gd-PEOz, loaded with doxorubicin) modified by PEOz and polydopamine-gadolinium ion network
[0047] The preparation method comprises the following steps:
[0048] (1) Dissolve 0.9g of cetyltrimethylammonium bromide and 1.5g of ammonium fluoride in 250mL of ultrapure water, heat up to 80°C, add 4.5mL of tetraethyl orthosilicate and 1g of mannose, and continue Stir for 10 hours, centrifuge at 15,000 rpm for 20 minutes, wash the precipitate and redisperse it in 250 mL of ammonium nitrate ethanol solution with a concentration of 5.6 mg / mL, reflux at 80°C for 18 hours, centrifuge at 15,000 rpm for 20 minutes, wash and dry to obtain doped Mesoporous silica nanoparticles infused with mannose;
[0049] (2) Disperse 50 mg of the above-mentioned mesoporous silica nanoparticles in 100 mL of doxorubicin ethanol solution with a concentration of 1 mg / mL, continue stirring for 9 hours, centrifuge at...
Embodiment 2
[0054] Example 2 Preparation of degradable mesoporous silicon nanoparticles (MSN-Man-DOX@PDA-Gd-PEOz, loaded with doxorubicin) modified by PEOz and polydopamine-gadolinium ion network
[0055] The preparation method comprises the following steps:
[0056] (1) Dissolve 1.5g cetyltrimethylammonium bromide and 1.0g ammonium fluoride in 250mL ultrapure water, heat up to 80°C, add 4mL tetraethyl orthosilicate and 1g mannose, and keep stirring 6 hours, centrifuged at 10000rpm for 30 minutes, washed the precipitate and redispersed it in 250mL ammonium nitrate ethanol solution with a concentration of 5.6mg / mL, refluxed at 80°C for 24 hours, centrifuged at 10000rpm for 30 minutes, washed and dried to obtain the doped Mesoporous silica nanoparticles of mannose;
[0057] (2) Disperse 50 mg of the above-mentioned mesoporous silica nanoparticles in 100 mL of doxorubicin ethanol solution with a concentration of 1 mg / mL, continue stirring for 6 hours, centrifuge at 10000 rpm for 30 minutes,...
Embodiment 3
[0061] Example 3 Preparation of degradable mesoporous silicon nanoparticles (MSN-Man-DOX@PDA-Gd-PEOz, loaded with doxorubicin) modified by PEOz and polydopamine-gadolinium ion network
[0062] The preparation method comprises the following steps:
[0063] (1) Dissolve 1.1g of cetyltrimethylammonium bromide and 1.3g of ammonium fluoride in 250mL of ultrapure water. After heating up to 80°C, add 5mL of tetraethyl orthosilicate and 1g of mannose, and keep stirring After 12 hours, centrifuge at 20000rpm for 15 minutes, wash the precipitate and redisperse it in 250mL ammonium nitrate ethanol solution with a concentration of 5.6mg / mL, reflux at 90°C for 12 hours, centrifuge at 20000rpm for 15 minutes, wash and dry to obtain the doped Mesoporous silica nanoparticles of mannose;
[0064] (2) Disperse 50 mg of the above-mentioned mesoporous silica nanoparticles in 100 mL of doxorubicin ethanol solution with a concentration of 1 mg / mL, continue to stir for 12 hours, centrifuge at 20000...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


